by APFLI | Jan 9, 2006 | Birth Control Archive
Clot Risk for Birth-Control Patch Is Double That of Pill FDA: Morning After Pill Decision Not Political HHS: State Health Departments NOT Required to Dispense EC/MAP UK: Thousands of 13-Year-Olds Given EC Without Parental Knowledge New Survey from Contraception...
by APFLI | Dec 5, 2005 | Birth Control Archive
Class Action Lawsuit Filed Against Depo-Provera (update!) Parents Sue After Their 14-Year-Old Daughter Died with Birth Control “Patch” IARC Monographs Programme Finds Combined Estrogen-Progestogen Contraceptives and Menopausal Therapy are Carcinogenic to...
by APFLI | Jan 28, 2005 | Contraception - Chemical Methods / Hormonal Contraception / Emergency / Morning After Pill
DEPO-PROVERA LABELED: LINKED TO BONE DENSITY LOSS The U.S. Food and Drug Administration (FDA) has issued a "black box warning" — the strongest possible FDA warning issued — to the labeling of the Depo-Provera drug, noting that extended use of...
by APFLI | Jan 1, 2005 | STDs, STIs, HIV - Archive
“An experimental drug in the form of a vaginal gel is being tested on female monkeys to prevent the HIV virus from gaining access to the body. The drug works by preventing the virus from penetrating a woman’s cells. “In many parts of the world, the...
by APFLI | Nov 27, 2004 | Contraception - Chemical Methods / Hormonal Contraception / Emergency / Morning After Pill
Depo Provera Increases Chance of Chlamydia, Gonorrhea Women who use the injected contraceptive Depo-Provera have a higher rate of sexually transmitted diseases, U.S. researchers [National Institutes of Health, UNC, and Johns Hopkins Univ in Baltimore] reported. This...
